Clinical trial
A Phase 2, Multicenter Open-Label Extension Study to Evaluate the Long-term Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
NCT06590896 is registered in ClinicalTrials.gov with Ono Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Multicenter Open-Label Extension Study to Evaluate the Long-term Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
- Lead sponsor
- Ono Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- November 4, 2022
- Completion date
- January 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.